Delisting risk
Niki BioSolutions (NIKI)
Develops blood-based brain-health diagnostics and provides molecular biomarker testing services.
$7.00
Pre-market+0.39 (+5.90%)
At close$6.61(−0.15%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Insiders2 holders · as of Aug 13, 2026 | 3.55% | 2.9K shares | |
| Otherremainder | 96.45% | 78.5K shares |
81.4K company shares as of Aug 21, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Institutions13F
No 13F holders on record.
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.